礼来Eli Lilly & Co. (LLY) 2013年年度报告「NYSE」.pdf

1、Determination Leads to DiscoveryELI LILLY AND COMPANY2013 ANNUAL REPORTNOTICE OF 2014 ANNUAL MEETINGPROXY STATEMENTYear in Review 1 Financial Highlights 2 Letter to Shareholders 6 Determination Leads to Discovery 12 Pipeline of Molecules in Clinical DevelopmentFinancials 2 Business 13 Risk Factors 1

2、9 Managements Discussion and Analysis of Results of Operations and Financial Condition 36 Consolidated Statements of Operations 37 Consolidated Statements of Comprehensive Income 38 Consolidated Balance Sheets 39 Consolidated Statements of Shareholders Equity 40 Consolidated Statements of Cash Flows

3、 41 Notes to Consolidated Financial Statements 76 Managements Reports 78 Reports of Independent Registered Public Accounting Firm 80 Selected Financial Data For more information on Lillys commitment to corporate responsibility,please see the inside back cover of this report.Proxy Statement 1 Notice

4、of Annual Meeting of Shareholders 2 Proxy Statement Overview 6 Board Operations and Governance 14 Director Compensation 16 Director Independence 17 Committees of the Board of Directors 19 Membership and Meetings of the Board and Its Committees 19 Board Oversight of Compliance and Risk Management 20

5、Highlights of the Companys Corporate Governance 23 Compensation Discussion and Analysis 36 Compensation Committee Matters 37 Compensation Committee Interlocks and Insider Participation 38 Executive Compensation 47 Ownership of Company Stock 48 Items of Business To Be Acted Upon at the Meeting 52 Mee

6、ting and Voting Logistics 54 Other Matters 55 Appendix A 57 Annual Meeting Admission Ticket 59 Executive Committee and Senior Leadership 60 Corporate InformationDetermination LeaDs to Discovery In 2013,Lilly demonstrated the determination that has been a hallmark of our company since its founding.We